IBDEI0ZK ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15864,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,15864,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,15865,0)
 ;;=L27.1^^88^869^306
 ;;^UTILITY(U,$J,358.3,15865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15865,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,15865,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,15865,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,15866,0)
 ;;=L29.0^^88^869^290
 ;;^UTILITY(U,$J,358.3,15866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15866,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,15866,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,15866,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,15867,0)
 ;;=L29.9^^88^869^291
 ;;^UTILITY(U,$J,358.3,15867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15867,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,15867,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,15867,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,15868,0)
 ;;=L30.0^^88^869^270
 ;;^UTILITY(U,$J,358.3,15868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15868,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,15868,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,15868,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,15869,0)
 ;;=L30.1^^88^869^143
 ;;^UTILITY(U,$J,358.3,15869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15869,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,15869,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,15869,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,15870,0)
 ;;=L30.2^^88^869^135
 ;;^UTILITY(U,$J,358.3,15870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15870,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,15870,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,15870,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,15871,0)
 ;;=L30.4^^88^869^147
 ;;^UTILITY(U,$J,358.3,15871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15871,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,15871,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,15871,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,15872,0)
 ;;=L30.8^^88^869^138
 ;;^UTILITY(U,$J,358.3,15872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15872,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,15872,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,15872,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,15873,0)
 ;;=L30.9^^88^869^139
 ;;^UTILITY(U,$J,358.3,15873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15873,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,15873,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,15873,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,15874,0)
 ;;=L40.0^^88^869^293
 ;;^UTILITY(U,$J,358.3,15874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15874,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,15874,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,15874,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,15875,0)
 ;;=L40.1^^88^869^296
 ;;^UTILITY(U,$J,358.3,15875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15875,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,15875,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,15875,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,15876,0)
 ;;=L40.2^^88^869^12
 ;;^UTILITY(U,$J,358.3,15876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15876,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,15876,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,15876,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,15877,0)
 ;;=L40.3^^88^869^295
 ;;^UTILITY(U,$J,358.3,15877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15877,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
